Company: STAA
Filing Date: 2025-12-10
Form Type: DEFA14A
Source: 0001193125-25-314435
Chunk: 5

Company: STAAR SURGICAL CO
Filing Date: 2025-12-10
Form: DEFA14A
Chunk 5
---
) Supplements to “Questions and Answers” The following questions and answers are hereby added to the section titled “Questions and Answers” beginning on page 12 of the proxy statement to address briefly some questions STAAR stockholders may have regarding this Supplement and the Second Amendment. This section does not contain all the information that is important to you, nor is this section meant to be a substitute for the information contained in the remainder of this Supplement or the proxy statement. The information in this section is qualified in its entirety by the more detailed descriptions and explanations contained elsewhere in this Supplement and the proxy statement. We urge you to read both this Supplement and the proxy statement carefully, including any information incorporated by reference into this Supplement and the proxy statement.

| Q: | Why are you filing this Supplement to the proxy statement? |

| A: | We are filing this Supplement to the proxy statement to inform STAAR stockholders about two updates: |

First, the go-shop period that was previously announced by STAAR expired on December 6, 2025, at 11:59 p.m., Eastern Time. During the go-shop period, STAAR, with the assistance of its financial advisor, Citi, actively solicited acquisition proposals from a wide range of potentially interested third parties. In total, STAAR or Citi engaged with 21 parties – including financial sponsors, potential strategic acquirers and the parties previously identified in the proxy statement as Party A, Party B and Party C. Two of the 21 parties signed a nondisclosure agreement and were provided diligence information by STAAR, but none of the 21 parties submitted an Acquisition Proposal. None of Party A, Party B and Party C signed a nondisclosure agreement. Second, on December 9, 2025, STAAR, Alcon and Merger Sub entered into Amendment No. 2 to the Agreement and Plan of Merger (the “Second Amendment”). This Supplement provides information about the go-shop process and the Second Amendment, including the increase to the Merger Consideration from $28.00 per share in cash to $30.75 per share in cash, and updates the proxy statement.

| Q: | What does the Second Amendment provide and why did the Board approve the Second Amendment? |

| A: | The Second Amendment, among other things, increases the Merger Consideration to be paid to the holders of                                                                             
 shares of STAAR common stock, if the Merger is consummated, from $28.00 per share in cash to $30